AC Immune amends Lilly collaboration for tau drug development
Go back to AC Immune amends Lilly collaboration for tau drug development| (NASDAQ: ACIU) | Delayed: 2.26 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.26 | 52 Week High | $19.97 | |||
| Open | $2.26 | 52 Week Low | $10.36 | |||
| Day High | $2.26 | P/E | N/A | |||
| Day Low | $2.26 | EPS | $0.00 | |||
| Volume | 582 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1160.95 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1160.95 | 52 Week High | $88.16 | |||
| Open | $1160.95 | 52 Week Low | $67.88 | |||
| Day High | $1160.95 | P/E | 268.74 | |||
| Day Low | $1160.95 | EPS | $4.32 | |||
| Volume | 4,794 | |||||

